Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Beijing Strong Biotechnolo-A (300406 CH)
Watchlist
8
Analysis
Health Care
•
China
Beijing Strong Biotechnologies, Inc. operates in the IVD industry, where they specialize in the manufacturing of clinical chemistry liquid reagents.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Beijing Strong Biotechnolo-A
•
03 Jun 2024 22:24
CSI Esoteric Index Rebals Jun 24: All Share Brokerage, China Internet, Medical, Defense, & Livestock
We expect the the CSI Medical Services ADDs to outperform the Medical Services DELs over the next few days. The Inclusion/Exclusion events could...
Janaghan Jeyakumar, CFA
Follow
421 Views
Share
bullish
•
Beijing Strong Biotechnolo-A
•
02 Jun 2024 11:00
CSI Medical Service Index Rebalance: Adds Could Outperform Deletes in the Coming Week
There are 5 changes for the index in June. We correctly forecast 3 adds and all 5 deletes. The adds outperformed the deletes post announcement in...
Brian Freitas
Follow
409 Views
Share
bullish
•
Inner Mongolia Furui Medical Scie
•
04 Nov 2024 13:40
Quiddity Leaderboard CSI Medical Dec 24: Final Rankings; Exp ADDs Underperforming Exp DELs
We expect the index changes to be announced after market close on 29th November 2024. We currently estimate one-way flow to be US$248mn. Most...
Janaghan Jeyakumar, CFA
Follow
264 Views
Share
bullish
•
Sinopep-Allsino Bio Pharmaceutical
•
15 Oct 2024 15:42
Quiddity Leaderboard CSI Medical Service Dec 24: US$271mn One-Way; 1x-4x ADV to Trade for Most Names
We estimate the CSI Medical December 2024 index rebalance to trigger flows of US$271mn one-way. Most of the expected ADDs/DELs have 1x-4x ADV to...
Janaghan Jeyakumar, CFA
Follow
393 Views
Share
bullish
•
Sinopep-Allsino Bio Pharmaceutical
•
23 Sep 2024 05:08
Quiddity Leaderboard CSI Medical Dec 24: 5 Changes Possible; Exp ADDs yet to Outperform Exp DELs
We expect US$187mn one-way flows. Most of the expected ADDs/DELs have 1x-4x ADV to trade. The expected ADDs have failed to outperform the the...
Janaghan Jeyakumar, CFA
Follow
443 Views
Share
1
2
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x